SGS has selected the European Centre for Clinical Research Training (ECCRT) for the provision of good manufacturing practice (GMP) training of its pharmacy team.
SGS has selected the European Centre for Clinical Research Training (ECCRT) for the provision of good manufacturing practice (GMP) training of its pharmacy team, the company announced in a Sep. 6, 2021 press release.
Through the collaboration, ECCRT will provide SGS’ pharmacy team with qualitative training and educational materials across multiple domains, including good practices (GxP), quality assurance (QA), and risk management. All training sessions will be provided across a choice of platforms, such as e-learning or webinars, in classrooms, or via a combination of in-person and virtual learning.
“We selected ECCRT for its ability to offer both open and tailored courses that perfectly match our requirements and can be adapted according to our teams,” said Carl Van Ingelgem, SGS training manager, in the press release. “We especially appreciate the flexibility and short turnover times shown by ECCRT to help us meet our needs.”
“We are very pleased to see the long-lasting collaboration crystallize in the present collaboration with SGS to have its teams trained to the latest standards,” added Prof. Benedikt Van Nieuwenhove, managing director of ECCRT, in the press release.
Source: SGS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.